Celera and Ipsen Enter Research Collaboration to Develop Pharmacogenomic Tests

Celera, an Applera Corporation business, and Ipsen announced that they have entered into a research collaboration to develop biomarker and pharmacogenomic tests for growth failure patients.
Genetic Engineering & biotechnology News